Date:February 2, 2016
Covance is looking for expressions of interest from companies involved in CAR-T and T Cell Receptor therapies, regarding non-invasive cell tracking in vivo. Covance is using a validated MRI platform that can be used to label T cells and detect/track cells in rodents.1 This strategy can also be implemented in NHP studies and clinical trials.2 Using MRI, the following can be quantified over time in living subjects:
- Tissue residence times/persistence
- Cell viability
- Engraftment patterns
- Clearance pathways
- Efficacy correlation with cell biodistribution
Please contact us today for more information.
1Srinivas at al., In Vivo Cytometry of Antigen-specific T Cells Using 19F MRI, Magn Reson Med. 2009 Sep;62(3):747-53. doi: 10.1002/mrm.22063.
2Ahrens et al., Clinical Cell Therapy Imaging Using a Perfluorocarbon Tracer and Fluorine-19 MRI, Magn Reson Med. 2014 Dec;72(6):1696-701. doi: 10.1002/mrm.25454. Epub 2014 Sep 19.